{"symbol":"ABBV","fiscalQuarter":"Q3-2023","reportDate":"2023-10-27","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2023","postBrief":{"headline":"AbbVie Beats on EPS, Stock Down 4.32%","keyNumbers":[{"metric":"EPS","actual":"$2.95","expected":"N/A","surprise":"+3.04%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on delivering value through our pipeline."],"summary":"Management expressed satisfaction with the EPS results, highlighting their commitment to pipeline development. However, they did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"AbbVie's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 4.32% in reaction, likely due to the lack of revenue information and absence of forward guidance. Investors may be concerned about future performance without clear direction from management.","metaDescription":"AbbVie Inc (ABBV) Q3 2023 earnings: EPS beat by 3.04%. Stock down 4.32%. Full breakdown."}}